Journal of Neurotrauma · 2021 · 15 citations · 30 references
MedicinePharmacotherapyRehabilitation MedicineCognitive NeurologyMemoryNeurologic PharmacotherapyCognitive ImpairmentCognitive RehabilitationNeurocognitive AssessmentTraumatic Brain InjuryAdverse Drug EventsCholinergic AgonistsCognitive Enhancement By Cholinergic AgentsNeurological Adverse EventsTraumatic Brain Injury PharmacotherapyTraumatic Brain Injury-related Cognitive ImpairmentVerbal Learning TestsVerbal Memory
= 0.24). Overall, there were no significant differences in changes for all secondary outcomes between the rivastigmine and placebo groups. The most commonly observed adverse events were application site reactions. This trial provides the largest sample to date of veterans with TBI and post-traumatic memory deficits enrolled in a pharmacological trial. Trial Registration: clinicaltrials.gov Identifier: NCT01670526.
30
An Inventory for Measuring Depression
Aaron T. Beck · Archives of General Psychiatry · 1961 · 38.2K citations
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq
Charles W. Hoge, Dennis McGurk, Jeffrey L. Thomas et al. · New England Journal of Medicine · 2008 · 2.8K citations · Full text